Cargando…

Probiotics and COVID-19 – Authors' reply

Detalles Bibliográficos
Autores principales:	Mak, Joyce W Y, Chan, Francis K L, Ng, Siew C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357987/ https://www.ncbi.nlm.nih.gov/pubmed/32673605 http://dx.doi.org/10.1016/S2468-1253(20)30197-7

Ejemplares similares

Probiotics and COVID-19: one size does not fit all
por: Mak, Joyce W Y, et al.
Publicado: (2020)

Reply
por: Xu, Zhilu, et al.
Publicado: (2021)

Reply
por: Zhang, Lin, et al.
Publicado: (2022)

Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic
por: Hu, Jielun, et al.
Publicado: (2021)

Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients
por: Su, Qi, et al.
Publicado: (2022)

Estimation of COVID-19 burden in Egypt – Authors' reply
por: Tuite, Ashleigh R, et al.
Publicado: (2020)

Authors’ reply
por: Durai, Rajaraman, et al.
Publicado: (2012)

Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Reply to: Probiotics for the Prevention of COVID-19 Sequelae
por: KURIAN, SHILIA JACOB, et al.
Publicado: (2022)

Author’s Reply—Is it really COVID-19?
por: Chang, David, et al.
Publicado: (2020)

Author’s reply
por: Park, Chan Hong
Publicado: (2019)

Nicaragua's response to COVID-19 – Authors' reply
por: Jarquín, Mateo C, et al.
Publicado: (2020)

Authors’ reply
por: Mishra, L D, et al.
Publicado: (2011)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Author’s Reply
por: Najar, M. S., et al.
Publicado: (2010)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

AUTHOR REPLY
por: Tabakin, Alexandra L., et al.
Publicado: (2021)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Authors’ reply
por: Shanmugam, Mahesh P, et al.
Publicado: (2015)

Author`s Reply
por: Taher, Ziad A., et al.
Publicado: (2019)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

COVID-19 in pregnant women – Authors' reply
por: Baud, David, et al.
Publicado: (2020)

Feasibility of controlling COVID-19 – Authors' reply
por: Eggo, Rosalind M, et al.
Publicado: (2020)

Authors' reply
por: Romero, Ivana L, et al.
Publicado: (2010)

Author's Reply
por: Madanat, Amal Y., et al.
Publicado: (2017)

AUTHOR'S REPLY
por: Gregorio, Sergio Alonso y, et al.
Publicado: (2013)

Authors' reply
por: Parikh, Mitul, et al.
Publicado: (2009)

AUTHOR'S REPLY
por: Rivas, Juan Gómez, et al.
Publicado: (2016)

Authors’ reply
por: Sreejith, P., et al.
Publicado: (2010)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

COVID-19 and preterm birth – Authors' reply
por: Choudhary, Rahul, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19 – Authors' reply
por: Taquet, Maxime, et al.
Publicado: (2021)

COVID-19 and myocardial infarction – Authors' reply
por: Katsoularis, Ioannis, et al.
Publicado: (2021)

Fluvoxamine for the treatment of COVID-19 – Author's reply
por: Reis, Gilmar, et al.
Publicado: (2022)

Authors’ Reply: Vaccination, payment, and COVID-19
por: Dotlic, Jelena, et al.
Publicado: (2021)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

AUTHOR REPLY
por: Heard, John R., et al.
Publicado: (2022)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

THE AUTHORS REPLY
por: Hutcheon, Jennifer A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_245dt3adbge8o7qto3q1aklfhb